We found evidence of PITX1 and ERα binding in only one fusion gene, SPINT2, indicating that the majority of the fusion genes identified in this study contribute to ovarian cancer by mechanisms other than this regulatory network. This evidence concerns the gene ESR1 and ovarian cancer.